| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 10 Feb 2026 | 30 Jan 2026 |
| Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/02/2026 inter alia to consider and approve the unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended 31st December 2025. The Board of Directors of the Company at its meeting held today, i.e., Tuesday, February 10, 2026, inter-alia, considered and approved Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. A copy of the said financial results is enclosed along with limited review reports issued by M/s. B S R and Co, Chartered Accountants (FRN - 128510W), Statutory Auditors of the Company. (As per BSE Announcement dated on: 10.02.2026) | ||
| Board Meeting | 15 Jan 2026 | 15 Jan 2026 |
| Disclosure under Reg 30 of SEBI LODR Regulations, 2015 - Issuance of a Corporate Guarantee for and on behalf of Nephrocare Health Care Services Philippines Inc., Step-down wholly owned subsidiary not exceeding USD 6.00 million | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
